Company profile: Thesan Pharmaceuticals
1.1 - Company Overview
Company description
- Provider of preclinical biopharmaceutical development focused on novel therapeutics for skin disorders.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Thesan Pharmaceuticals
Union Biometrica
HQ: United States
Website
- Description: Provider of high-throughput large-particle (10-1500 micron) flow cytometry systems for analyzing, sorting and dispensing objects too large or fragile for traditional cytometers. Products include COPAS FP, BioSorter and VISION for sorting by size, length, optical density and multiple fluorescence channels. Systems handle cells, cell clusters and small model organisms. VAST BioImager enables automated high-throughput, high-content screening and cellular-resolution imaging of zebrafish larvae.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Union Biometrica company profile →
Phasefocus
HQ: United Kingdom
Website
- Description: Provider of Virtual Lens and ptychographic imaging technologies that generate high-definition amplitude and phase images without high-quality lenses for optical, X-ray and electron microscopy. Products include Livecyte, a label-free system to track and analyze live cell behavior, and πBox, a ptychographic reconstruction engine for electron microscopy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phasefocus company profile →
Visikol
HQ: United States
Website
- Description: Provider of CRO services focused on digital pathology, 3D tissue imaging, and 3D cell culture assays/models. Delivers end-to-end 2D/3D in vitro models, tissue clearing (Visikol HISTO) and confocal microscopy, high content screening, bio-imaging, bioinformatics and image analysis, plus custom drug discovery solutions and 21 CFR Part 11 compliant digital pathology software.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Visikol company profile →
Syndesi Therapeutics
HQ: Belgium
Website
- Description: Provider of drug candidates and molecules that uniquely modulate the synaptic vesicle protein SV2A to regulate synaptic transmission, representing a promising approach to treating Alzheimer’s disease and other neurological disorders with cognitive impairment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syndesi Therapeutics company profile →
Innova Biosciences
HQ: United Kingdom
Website
- Description: Provider of antibody labeling and bioconjugation kits and labeling reagents; develops, manufactures, and commercializes reagents that are marketed worldwide via a direct salesforce and a well-established distribution network.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Innova Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Thesan Pharmaceuticals
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Thesan Pharmaceuticals
2.2 - Growth funds investing in similar companies to Thesan Pharmaceuticals
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Thesan Pharmaceuticals
4.2 - Public trading comparable groups for Thesan Pharmaceuticals
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →